Skip to main content

Animations

MJFF Publications

3121 - 3130 of 8808 Results
Title
Year
  • Year
  • 2019
  • 2020
  • 2025
  • 2018
  • 2025
  • 2019
  • 2017
  • 2023
  • 2015
  • 2019
  • Summary Details
    RESTRICTED
    Title: Correlation analysis of [18F]ROStrace using ex vivo autoradiography and dihydroethidium fluorescent imaging in lipopolysaccharide-treated animals
    Journal Name: Biochemical and Biophysical Research Communications
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbrc.2019.06.062
    Citation Count: 7
  • Summary Details
    OPEN
    Title: A Failed Future
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: public-domain
    DOI - Digital Object Identifier: 10.1002/mds.28130
    Citation Count: 4
  • Summary Details
    OPEN
    Title: LRRK2 p.G2385R and p.R1628P variants in a multi-ethnic Asian Parkinson’s Cohort: epidemiology and clinical insights
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41531-025-01166-x
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Subthalamic nucleus deep brain stimulation reduces freezing of gait subtypes and patterns in Parkinson's disease
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.brs.2018.08.016
    Citation Count: 9
  • Summary Details
    RESTRICTED
    Title: Lasmiditan ameliorates cortico-hippocampal pathology and improves cognition in aging parkinsonian mice
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2025.115502
    Citation Count: 0
  • Summary Details
    OPEN
    Title: LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.104626
    Citation Count: 88
  • Summary Details
    OPEN
    Title: Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2017.12.005
    Citation Count: 125
  • Summary Details
    OPEN
    Title: Sleep disorders and mortality: A prospective study in the Canadian longitudinal study on aging
    Journal Name: Sleep Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.sleep.2023.12.023
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2015.03.008
    Citation Count: 27
  • Summary Details
    RESTRICTED
    Title: Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson’s disease
    Journal Name: Clinical Autonomic Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s10286-019-00632-w
    Citation Count: 16
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.